FIELD: medicine, narcology. SUBSTANCE: innovation deals with elaborating preparations against pathological addiction and abstinence syndrome in case of opium narcomania. For increasing the number of curative preparations the following peptide compound CP - Arg-Pro-Lys-Pro-Gln- Gln-Phe-Gly-Leu-Met-NH2 of low therapeutic properties should be used in composition with AntiCP - Arg-Pro- Lys-Pro-Gln-Gln-Phe-Phe-D-Pro-(spiro-gammalactam)- Trp-NH2. The innovation enables to considerably increase efficiency in treating opium narcomania. EFFECT: higher efficiency of therapy. 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT USED IN PROPHYLAXIS AND TREATMENT OF OPIOMANIA | 2002 |
|
RU2264228C2 |
| AGENT FOR PREVENTION AND TREATMENT OF ALCOHOLISM AND OPIOMANIA | 2008 |
|
RU2393864C1 |
| METHOD FOR TREATING AS DEPENDENT ON OPIATES DURING THE EXPERIMENT | 0 |
|
SU1803105A1 |
| IMMUNOGEN FOR TREATING AND PREVENTING OPIATE ADDICTION | 2013 |
|
RU2548802C1 |
| AGENT FOR ARRESTING AN ABSTINENT SYNDROME AT OPIOMANIA | 1996 |
|
RU2116084C1 |
| AGENT FOR ABSTINENT SYNDROME ARRESTING AT OPIOMANIA | 1993 |
|
RU2083204C1 |
| AGENT POTENTIATING MORPHINE HYDROCHLORIDE ANALGETIC EFFECT | 2001 |
|
RU2213572C2 |
| 17ALPHA,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE 17ALPHA,21-DIACETATE SHOWING ANTIALCOHOLIC AND ADAPTOGENIC ACTIVITY | 1999 |
|
RU2172173C2 |
| CHLOROHYDRATE OF TETRAPEPTIDE Trp-Nle-Asp-Phe-NH-CH(CH), INHIBITING MORBID ATTRACTION TO MORPHINE | 2008 |
|
RU2397990C2 |
| ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
